Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in Major Depression with Atypical Features
NCT00610506Phase 3Completed
- Sponsor
- Duke University
- Start
- Oct 2005
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in Major depressive disorder with atypical features (MDD-AF), sponsored by Duke University. Started Oct 2005; status: completed.
02
Drugs
escitalopram
03
Conditions
Major depressive disorder with atypical features (MDD-AF)
Beyond the preview
Go deeper on NCT00610506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610506.